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FOLLOWING the basic investigations of Huggins, Grand and Brillantes (1961),
Huggins, Briziarelli and Sutton (1959) and Dao (1964) it is readily possible to
induce mammary cancers in female Sprague-Dawley rats by administration of
3-methylcholanthrene or 7,12-dimethylbenzanthracene (DMBA), thus allowing
the behaviour of these tumours to be studied under various conditions. As has
been established particularly by Huggins, Grand and Brillantes (1961), and
Furth (1961), the growth of these tumours depends on hormone state in the
organism of the experimental animals, and may be reduced by male hormones
(testosterone) or stimulated by female hormones (oestrogens, progesterone).
Dao (1964) showed that mammary cancers can also be induced in rats by oestrogens
alone so that a carcinogenic effect of female hormones cannot be excluded.
The application of carcinogenic hydrocarbons mentioned is very frequently
accompanied by acute toxic phenomena and leads in many cases to the death ofthe
animals. Only when quite definite dose-time-relationships are noticed will these
toxic effects be minimized. The purpose of our own studies was to check the
possible existence of dose-effect-relations for testosterone in influencing the
growth of DMBA-induced mammary cancer in rats by this androgen. The
development of tumours following DMBA treatment has been noted and the
growth rates of tumours which formed at different times have been compared
with one another.
MATERIAL AND METHODS
Female Sprague-Dawley rats aged 51 to 58 days were used. The animals were
fed with a standard biscuit diet according to Kiissner (Heise and Gorlich, 1964)
and water given ad libitum. The mammary cancers were induced by three
gastric intubations of 10 mg. of DMBA in 1 ml. of sunflower oil at intervals of
7 days (Engelhart and Gericke, 1964). All DMBA treated animals were examined
three times a week for tumours. The time interval between the first DMBA
application and the moment the tumours become palpable will be referred to as
the induction time. The growth of the individual tumours was checked by
measuring two diameters three times a week. These diameters were multiplied
by each other and the value obtained was plotted against time. For therapy some
of the animals were injected with varying testosterone dosages which are listed in
Table IV. The testosterone preparation was an oily solution of testosterone
propionate (VEB Jenapharm), which was injected intramuscularly.E. HEISE AND M. GORLICH
RESULTS
In 51 ofthe 53 animals under experiment, i.e. in 96 per cent, at least one tumour
developed within 200 days. After 270 days there was a total of 134 tumours so
that an average of 2-7 tumours per animal was observed. The percentage occur-
rence of all tumours at certain time intervals after the beginning of DMBA treat-
ment may be seen in Table I. The most frequent induction time was 50 to 60
TABLE I.-Frequency of Incidence of Mammary Tumours
Period of
induction Number of
(days) tumours Per cent
0-39 . 0 . 0
40-49 . 3 . 22
50-59 . 9 60
60-69 25 . 18-7
70-79 . 11 8-2
80-89 17 . 12-7
90-99 . 16 . 12-0
100-109 14 10-4
110-119 7 . 52
120-129 . 4 . 3-0
130-139 . 4 3-0
140-149 4 . 30
150-159 3 . 2-2
160-169 . 4 . 30
170-179 2 . 1-6
180-189 3 2- 2
190-199 1 . 0-8
Over 200 . 7 . 52
days, whereas latent periods exceeding 110 days were noted in only a few cases.
This table covers the induction times of all tumours without making a difference
between " primary tumours " and " secondary tumours ". Since the first appear-
ance of a tumour in an animal gives a characteristic parameter of the process of
carcinogenesis and permits evidence to be obtained of the body's own defence, we
list in Table II the percent occurrence ofthe different induction times of " primary
TABLE II.-Frequency ofIncidence ofAppearance ofthe First Tumour
in an Animal
Period of Number of animals
induction bearing at least one
(days) tumour Per cent
0-39 0 . 0
40-49 . 2 3-9
50-59 6 . 11-8
60-69 20 39 0
70-79 . 7 13- 7
80-89 5 9- 8
90-99 1 1*9
100-109 . 2 39
110-119 3 5-9
120-129 2 3.9
above 130 3 5- 9
tumours" in the animals under experiment. This table shows clearly that the
average of60 to 70 days is, for more than one-third of the experimental animals, a
parameter of the duration of the process of carcninogeesis. The growth rates of
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DMBA-induced tumours vary widely. Like Young and Cowan (1963), we
observed, besides continuously growing carcinomas, tumours whose growth
stagnated on having reached a definite size. However, this stagnation was
abolished in many cases after a certain time interval, and was followed by rapid
growth (Fig. 1). The reason for this sudden growth potential is unknown, but it
must certainly be a break-down of the body's own defence or a breakdown of
the partial growth regulation ofthese tumours which is still present atthe beginning
of their development. Also, many tumours showed a spontaneous regression,
the reason for which is unknown. Like the stagnating tumours, the spontaneous
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regression of some of the carcinomas is not absolute, but temporarily limited.
TI'able III gives the percentage proportion of growing, stagnating and regressing
TABLE III. Distribution of Tendency of Growth
Present Young and Cowan
authors (1963)
Tendency of growth (per cent) (per cent)
Growing 244 204
Remaining . 274 . 52
thereof later growiing 100
Regiressing 181 271
thereof later growing 10 0
tumours in the total number oftumours compared with analogous values obtained
by Young and Cowan (1963). As may be seen from this table, there is a consider-
able difference between Young's data and our own, the possible reason for which
will be dealt in the discussion.
Histological examinations of the DMBA-induced mammary carcinomas
revealed that fibroadenomas (3 cases) occurred in addition to adenocarcinomas
in a very few cases, the growth rate of these was no lower than that of the adeno-
carcinomas. The differentiation of the adenocarcinomas, however, is very dif-
ferent. Besides the pure papillomas, we observed carcinomas showing papillary,
partly solid or completely solid growth.
541E. HEISE AND M. GORLICH
As already mentioned, we tried to influence the growth of the mammary
cancer by means ofhormone therapy. Only growing tumours were used for these
investigations, and the effect oftestosterone on stagnating or regressing carcinomas
was not taken into account. We used five testosterone dosages and followed
the growth tendency of the tumours during therapy.
TABLE IV.-Response of Growth of Tumours in Relation to the
Dosage of Testosterone
Dosage of Response of tumours
testosterone .-A.
mg./kg. body " +"
weight per cent per cent
30 daily 0 100
12 daily 33-3 66-7
6 daily . 36- 5 63 5
6 twice a week 88-0 12-0
3 twice a week 500 20- 0
Table IV shows the susceptibility of the tumours to hormone therapy, where
-+ " indicates a continuous regression ofthe tumour under a definite testosterone
dosage, and "- " indicates the complete absence of any influence on growth or
only a short-term (3 to 5 days) stagnation or regression. The different testo-
sterone doses were given daily (6 times per week) or twice a week. Table IV.
which covers a total of 54 tumours, shows clearly that the effect of testosterone
on the tumour growth is dependent on the hormone dosage. The fairly high
testosterone dosage of 30 mg./kg. ofbody weight daily did not lead to a regression
of the tumour in a single case. A comparison between the growth curves of
untreated tumours and those whose host animal had received these high testo-
sterone dosages, indicated that in some cases the growth rate ofthe treated tumours
is even higher than that of the untreated carcinomas. An example of this beha-
viour is given in Fig. 2. It must be added, however, that this finding is not
absolutely valid, since a discontinuous course of growth was observed in many
normal cases too. As may be seen from Table IV, treatment with very low
testosterone dosages (6 and 3 mg./kg. ofbody weight twice a week) led to a regres-
sion of the tumours in more than 80 per cent of the cases. A growth rate of this
type is shown in Fig. 3. According to Huggins' terminology, the unaffected cases
should be termed " hormone-independent ". A similar independence is possibly
present also in some tumours which do not show any influence when treated with
high testosterone dosages. We also noticed that single tumours, the host animals
ofwhich were given 12 or 6 mg. oftestosterone/kg. ofbody weight a day, showed a
response immediately after beginning the therapy which, however, was followed
within a short time by rapid growth. We suppose that these tumours grew
"hormone-independent " only in the course of continued therapy.
Oophorectomy on several animals led to a marked regression of the tumours
in the majority of cases, although there were examples of complete absence of any
influence on growth.
We furthermore tried to establish a relation between the growth tendency of
the tumours and the time of their appearance after treatment with DMBA.
Although no obvious connection could be found, we must point out that no one
tumour with an induction time of over 200 days, could be classed as a growing
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30 mg.Testosterone perkg.
body weightdaily I
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FIG. 2.-The influence ofhigh dosage of testosterone on the growth of mammary tumours.
6mg.Testosterone per kg. body weight
twice aweek
10
FiG. 3.-The influence of weak dosage of testosterone on the growth of mammary tumours.
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tumour. On the other hand, there was only one tumour out of 20 spontaneously
regressing tumours which had an induction time ofless than 80 days. The growth
rate of the growing tumours, however, is independent of the induction time, but
it was striking that 78 per cent of these carcinomas had an induction time of less
than 110 days.
DISCUSSION
The present results show that the growth tendency of the DMBA-induced
mammary carcinomas of the rat is very different. Contrary to the results pub-
lished by Young and Cowan (1963), we found more than 50 per cent ofthe induced
carcinomas to be growing tumours. This difference is not easy to explain, since
the age and strain of the animals and the time of examination were the same in
both cases. However, Young and Cowan induced the mammary carcinomas by
single application of 50 mg. DMBA by means of intubation, while in our experi-
ments the animals were given three times 10 mg. ofDMBA through gastric intuba-
tion. It may be that the fairly toxic dosage of Young and Cowan, according to
Huggins and Morii (1961) also has an influence on the growth tendency of the
carcinomas induced. Necrosis of the adrenal glands, frequently observed with
high DMBA dosage, leads possibly to a change in the hormonal state ofthe whole
organism and may be responsible too for the spontaneous regression ofsome mam-
mary carcinomas. Thus there might exist a direct proportionality between the
frequency of spontaneous regressions and the quantity of DMBA applied.
The effect of different testosterone dosages as presented in Table IV on the
growth ofmammary carcinomas permits the conclusion that possibly a part ofthe
administered testosterone is converted into oestradiol in the organism ofthe female
rat, the stimulative effect of which on the growth of mammary carcinomas has
already been described (Huggins, Briziarelli and Sutton, 1959). On the other
hand it could be possible that there exists a similar biphasic effect of testosterone
as has been suggested by Tata (1964) for the action of thyroxine on the different
molecular levels.
The growth-inhibiting effect oflow testosterone dosages could be observed also
with fibroadenomas, so that malignancy and hormone dependency do not appear
to be causally related. It may be assumed that testosterone cancels the break-
down in growth regulation invariably occurring in fibroadenomas too, and that
quantitative relations possibly exist between the effect of hormones and the
controllability of certain enzymes which are essential for growth.
SUMMARY
1. Mammary carcinomas were induced in female Sprague-Dawley rats in
96 per cent ofthe casesbythree administrations of10 mg. dimethylbenzanthracene.
The induction time of the carcinomas varied from 40 to 270 days. More than
50 per cent of 134 tumours had a positive trend in growth, whereas less than 20 per
cent showed spontaneous regression.
2. High dosages of testosterone (30 mg./kg. of body weight a day) did not
produce any inhibition to the tumour growth, and even stimulated the growth
in some cases. Testosterone dosages of6 or 3 mg./kg. ofbody weight administered
twice a week caused the tumours to regress in more than 80 per cent of the cases.
Non-responsive tumours should be termed " hormone-independent " according to
Huggins.
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3. No relation exists between the induction period and the growth tendency
or the growth rate of the tumours.
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